Distribution of the first doses of a coronavirus vaccine could be mere months away. But how that distribution will work remains a massive logistical puzzle that is still coming together piece by piece. NPR's Selena Simmons-Duffin reports on how drug companies and the federal government are planning to ship and store vaccines that must remain frozen, some at temperatures that require special freezers. NPR's Dina Temple-Raston outlines the federal government's $590 million plan to avoid shortages of crucial vials and syringes. In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Nachrichten
Consider This from NPR Folgen
The hosts of NPR's All Things Considered help you make sense of a major news story and what it means for you, in 15 minutes. New episodes six days a week, Sunday through Friday.Support NPR and get your news sponsor-free with Consider This+. Learn more at plus.npr.org/considerthis
Folgen von Consider This from NPR
1680 Folgen
-
Folge vom 19.11.2020Vials, Cold Storage, Staggered Doses: The Challenges Of Vaccine Distribution
-
Folge vom 18.11.2020America's Other Epidemic: The Opioid Crisis Is Worse Than 4 Years AgoDuring President Trump's first year in office, 42,000 Americans died of drug overdoses linked to heroin, fentanyl and prescription opioids. After a minor decrease in 2018, deaths rose to a record 50,042 in 2019. That number will likely be even worse for 2020. NPR's Brian Mann reports on the surge of synthetic fentanyl, especially in the western U.S. And NPR's Emily Feng unveils a web of Chinese sellers exporting individual chemical components to produce fentanyl. In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 17.11.2020Vaccine Trials Point To December Doses, 'Light At The End Of The Tunnel'Data from two leading COVID-19 vaccine trials indicate they may be between 90 and 95% effective. Dr. Moncef Slaoui, the chief scientist in charge of the U.S. government's vaccine development program, Operation Warp Speed, tells NPR he's optimistic there is "a light at the end of the tunnel."Dr. Anthony Fauci told NPR the results are worth celebrating — but that they should not be seen as a signal to pull back on public health measures. He also said the first vaccine doses may be available next month. But it will still be months longer before any vaccine is widely available. Two former government health officials — Scott Gottlieb and Andy Slavitt — tell NPR that in the meantime, the pandemic is could kill 200,000 more Americans. In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 16.11.2020Barack Obama On Trump's Defeat And Cooperation In A Divided AmericaFormer President Barack Obama talks with NPR's Michel Martin about his time in office, President Trump's pandemic response, the 2020 election and what he thinks President-elect Joe Biden says about the United States right now. In Obama's new memoir, A Promised Land, he writes about his first term in the White House. Read NPR's full interview with Obama here.In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy